Terms ending in 2029
Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,084,612 | Proline Analogs as Ligands for Cannabinoid Receptors In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,181,772 | Dispenser with Corner Latches In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,298,579 | Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,637,073 | Treatment of Dependence Withdrawal In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,149,436 | Pharmaceutical product comprising a sequestered agent In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,476,271 | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,145,408 | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| US 9,890,164 | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| US 10,519,156 | 9'-AZA[3,9'-BI(BICYCLO[3.3.1]NONAN)]-3'-ONE and Preparation Thereof In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| US 11,111,246 | Pharmaceutical Salts of Substituted-Quinoxaline-Type Bridged-Piperidine Compounds In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| 12 more term ends in 2029 · Pro | |||||
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
21 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.